Balaji Krishnamachary1, Mayur Gadiya2,
Noriko Mori1, Yelena Mironchik1, Kristine Glunde1,
Zaver M. Bhujwalla1
1JHU ICMIC Program, Russell H. Morgan
Department of Radiology & Radiological Science, The Johns Hopkins
University School of Medicine, Baltimore, MD, United States; 2JHU
ICMIC Program, Russell H. Morgan Department of Radiology & Radiological
Science, The Johns Hopkins University School of Medicine, Baltimore, MD,
United States
A
hallmark of cancer is an increase of cellular phosphocholine (PC) and total
choline-containing compounds (tCho), which are closely related to malignant
transformation, invasion and metastasis.
Enzymes in choline metabolism present attractive targets that can be
exploited for treatment. Here we have
shown that at least two of these enzymes are interdependent. Downregulation of choline kinase (Chk) with
siRNA results in increased phospholipase D1 (PLD1) expression and
downregulation of PLD1 results in increased Chk expression, typifying the
ability of cancer cells to adapt.
These data support multiple targeting of enzymes in the choline
pathway using a multiple siRNA approach.